Business Context and Reporting Period
This Form 6-K filing by STMicroelectronics N.V. covers the month of May 2002. The report discloses a strategic alliance announced on May 27, 2002, between STMicroelectronics and Dai Nippon Printing Co., Ltd. (DNP) focused on the development and supply of photomasks, which are critical components for silicon integrated circuits.
Key Financial Metrics
The filing does not provide current period revenue, profit, cash flow, margins, debt, or liquidity figures. It references historical data for context:
- STMicroelectronics 2001 Net Revenues: $6.36 billion
- STMicroelectronics 2001 Net Earnings: $257.1 million
- DNP Fiscal 2001 Net Sales: Over $10.8 billion
- Proposed Capital Investment: Approximately $150 million over three years for the new joint venture facility.
Material Changes and Strategic Developments
The primary material change is the formation of a new entity, DNP Photomask Europe, supported by equity shareholding from STMicroelectronics. Key operational details include:
- Facility Location: A new photomask production facility will be built next to ST's site in Agrate, near Milan, Italy.
- Timeline: Operations are expected to commence around mid-2003.
- Employment: The facility is projected to employ approximately 100 people.
- Supply Agreement: DNP will become ST's primary supplier for leading-edge and high-end photomasks.
- Technology Integration: The alliance includes a technology agreement to ensure seamless integration of new photomasks into ST's wafer fabrication processes, targeting 130 and 90 nanometer technologies.
Outlook, Management Commentary, and Risks
Management views this alliance as essential for maintaining momentum in the rapidly evolving semiconductor industry. Pasquale Pistorio, President and CEO of STMicroelectronics, emphasized that closer supply chain relationships are necessary to sustain the pace of semiconductor evolution. The partnership aims to reduce product development times and secure early access to mask supply.
Risks and Contingencies: The filing does not explicitly list financial risks or contingencies. However, the success of the initiative relies on the timely construction of the Agrate plant and the successful integration of DNP's photomask technology with ST's advanced manufacturing processes.
Investor Verification Checklist
- Verify the equity structure and ownership split of the new DNP Photomask Europe entity.
- Confirm the specific terms of the long-term supply agreement regarding volume commitments and pricing.
- Monitor the construction progress and capital expenditure schedule for the Agrate facility against the $150 million estimate.
- Assess the impact of this alliance on ST's gross margins given the shift to a primary supplier relationship.
- Review subsequent filings for updates on the mid-2003 operational start date.